Benzinga | Nov 3, 2020 08:07AM EST

Epizyme, Inc. Granted Patent by USPTO Number 10,821,113 Dated November 3, 2020 Titled 'Salt form of a human histone methyltransferase EZH2 inhibitor'

Epizyme, Inc. Granted Patent by USPTO Number 10,821,113 Dated November 3, 2020 Titled 'Salt form of a human histone methyltransferase EZH2 inhibitor'